Lanxess: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
Global PDF: US$ 4,100.00
A strategic assessment of Bayer/Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 43 pages and 7 tables
A strategic assessment of Bayer/Lanxess, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 43 pages and 7 tables
Contents
I. EXECUTIVE SUMMARYII. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
LIST OF TABLES
Table 1: Bayer Sales by Business Segment
Table 2: Bayer Sales Growth by Business Segment
Table 3: Bayer Sales by Geographic Region
Table 4: Bayer Sales Growth by Geographic Region
Table 5: Lanxess Sales and Operating Profit Growth
Table 6: Lanxess Sales by Product Line
Table 7: Lanxess Sales Growth by Product Line
Skip to top